Artículos por temáticas

Neuroprotective mechanism of LincRNA in neurodegenerative diseases

Lin Y, Wang J, Liu B, Hu T, Gu J.

Gene. 2025 Oct 5;967:149722. doi: 10.1016/j.gene.2025.149722. Epub 2025 Aug 13.

Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases

Zota I, Calogeropoulou T, Chanoumidou K, Charalampopoulos I, Gravanis A.

Br J Pharmacol. 2025 Oct;182(19):4466-4489. doi: 10.1111/bph.70143. Epub 2025 Jul 23.

Effectiveness of Electroencephalographic Neurofeedback for Parkinson's Disease: A Systematic Review and Meta-Analysis

von Altdorf LAWR, Bracewell M, Cooke A.

J Clin Med. 2025 Sep 30;14(19):6929. doi: 10.3390/jcm14196929.

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases

Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani T, Preller KH, Taylor JP, Waters F, Winston BS, Leptourgos P.

Schizophr Bull. 2025 Oct 6;51(Supplement_3):S273-S291. doi: 10.1093/schbul/sbaf068.

Re-Emergent Tongue and Jaw Tremor in Parkinson's Disease: A Case Series and a Literature Review

Ueno SI, Takai I, Takeshige H, Nakajima S, Oji Y, Nishikawa N, Hatano T.

Mov Disord Clin Pract. 2025 Oct 6. doi: 10.1002/mdc3.70386. Online ahead of print.

Viral infections and the risk of neurodegenerative diseases: a comprehensive meta-analysis and systematic review

Liu RY, Yin KF, He SY, Su WM, Duan QQ, Wen XJ, Chen T, Shen C, Li JR, Cao B, Chen YP.

Transl Psychiatry. 2025 Oct 10;15(1):388. doi: 10.1038/s41398-025-03639-2.

Recent advances in potential mechanisms of epidural spinal cord stimulation for movement disorders

Zhang T, Jia Y, Wang N, Chai X, He Q, Cao T, Mu Q, Lan Q, Zhao J, Yang Y.

Exp Neurol. 2025 Oct;392:115330. doi: 10.1016/j.expneurol.2025.115330. Epub 2025 Jun 4.

Crosstalk between bladder-cardiovascular autonomic nervous system in synucleinopathies

Sakakibara R, Uchiyama T, Yamamoto T.

Auton Neurosci. 2025 Oct;261:103320. doi: 10.1016/j.autneu.2025.103320. Epub 2025 Jul 9.

The silent invaders: Biofilms in neurological, cardiovascular, and metabolic diseases

Kumar V, Tyagi A.

Life Sci. 2025 Oct 15;379:123886. doi: 10.1016/j.lfs.2025.123886. Epub 2025 Jul 30.

Effect of Elevation Training Mask on Swallowing Function in Individuals with Parkinson's Disease

Nachalon Y, Shpunt D, Zait A, Oestreicher-Kedem Y, Hayat L, Ashkenazi Y, Nativ-Zeltzer N, Belafsky PC, Maayan Eshed G, Gurevich T, Manor Y.

Dysphagia. 2025 Oct;40(5):1184-1190. doi: 10.1007/s00455-025-10815-5. Epub 2025 Feb 25.

A PLAN to address the Parkinson pandemic

Dorsey ER, Okun MS, Bloem BR.

J Parkinsons Dis. 2025 Oct 21:1877718X251378115. doi: 10.1177/1877718X251378115. Online ahead of print.

Targeting ASK1 signaling in neurodegeneration: molecular insights and therapeutic promise

Sulthana N, Mittal P, Goyal A, Ballal S, Maharana L, Rana AJ, Khan Y, Goyal K, Mishra R, Ali H, Gupta G, Hussain MS.

Apoptosis. 2025 Oct;30(9-10):2019-2041. doi: 10.1007/s10495-025-02148-3. Epub 2025 Jul 23.

Recent and on-going trials for the treatment of levodopa-induced dyskinesia: a review of the clinical trial databases

Al-Kassmy J, Alsalmi M, Kang W, Palayew M, Huot P.

Neurodegener Dis Manag. 2025 Oct;15(5):235-244. doi: 10.1080/17582024.2025.2528557. Epub 2025 Jul 5.

Unveiling Tirzepatide's Therapeutic Spectrum: A Dual GIP/GLP-1 Agonist Targeting Metabolic, Neurological, and Cardiovascular Health

Ghaleb J, Khouzami KK, Nassif N, Attieh P, Ajlani MFA, Sleiman JB, Khalouf A, Harb F, Azar S, Kannan A, Ghadieh HE.

Int J Endocrinol. 2025 Oct 1;2025:2876156. doi: 10.1155/ije/2876156. eCollection 2025.

Further delineation of LRSAM1-related Charcot-Marie-Tooth type 2P with parkinsonism

Ducatel P, Verger A, Selton M, Renaud M, Puisieux S, Grosset A, Hopes L, Michaud M.

Eur J Med Genet. 2025 Oct;77:105032. doi: 10.1016/j.ejmg.2025.105032. Epub 2025 Jul 26.